Injectable contraceptive, the promising alternative
Koetsawang, S.
Journal of the Medical Association of Thailand 58(12): 606-613
1975
ISSN/ISBN: 0125-2208 PMID: 1206260 Document Number: 89653
Document emailed within 1 workday
Related Documents
Beksinska, M.E.; Rees, V.H.; Nkonyane, T.; McIntyre, J.A. 1998: Compliance and use behaviour, an issue in injectable as well as oral contraceptive use? a study of injectable and oral contraceptive use in Johannesburg British Journal of Family Planning 24(1): 21-23Beksinska, M.E.; Rees, V.H.; Nkonyane, T.; McIntyre, J.A. 1998: Compliance and use behaviour, an issue in injectable as well as oral contraceptive use? a study of injectable and oral contraceptive use in Johannesburg British Journal of Family Planning 24(1): 21-23
Ahmad, M.M.; Ghazala, A. 1986: Some metabolic effects of long term use of the injectable contraceptive norigest and oral contraceptive noriday Journal of Endocrinology 111(Suppl)
Et Al 1984: Comparative evaluation of contraceptive efficacy of norethisterone enanthate 200 milligram injectable contraceptive given every 2 or 3 months Contraception 30(6): 561-574
Et Al 1984: Comparative evaluation of contraceptive efficacy of norethisterone enanthate 200 milligram injectable contraceptive given every 2 or 3 months Contraception 30(6): 561-574
Sagili, H.; Divers, M. 2008: Hysteroscopic sterilisation with Essure: a promising new alternative to tubal ligation? Journal of Family Planning and Reproductive Health Care 34(2): 99-102
Lygidakis, N.J.; Dedemati, G.; Spenzaris, N.; Theodoropoulou, M. 1997: Unresectable pancreatic cancer: is a multi-modality approach a promising therapeutical alternative? Hepato-Gastroenterology 44(16): 1222-1228
Thompson, D.F. 1987: Alternative packaging needed for injectable drugs American Journal of Hospital Pharmacy 44(8): 1775
1992: New contraceptive vaccines, implants may prove promising Contraceptive Technology Update 13(1): 18-19
Smit, J.A.; Beksinska, M.E. 2013: Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV Journal of Acquired Immune Deficiency Syndromes 62(3): 363-365
Smit, J.A.; Beksinska, M.E. 2013: Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV Journal of Acquired Immune Deficiency Syndromes 62(3): 363-365
Smit, J.A.; Beksinska, M.E. 2013: Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV Journal of Acquired Immune Deficiency Syndromes 62(3): 363-365
Molina, R.C.; Sandoval, J.Z.; Montero, A.V.; Oyarzún, P.G.; Molina, T.ís.G.; González, E.A. 2009: Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents Journal of Pediatric and Adolescent Gynecology 22(1): 25-31
Simon, P. 1970: An injectable contraceptive with prolonged action Therapeutique 46(10): 1029-1032
Gray, R.H. 1979: Norethisterone oenanthate as an injectable contraceptive British Medical Journal 1(6159): 343
Konstantinus, I.N.; Balle, C.; Jaumdally, S.Z.; Galmieldien, H.; Pidwell, T.; Masson, L.; Tanko, R.F.; Happel, A.-U.; Sinkala, M.; Myer, L.; Bosinger, S.E.; Gill, K.; Bekker, L.-G.; Jaspan, H.B.; Passmore, J.-A.S. 2020: Impact of Hormonal Contraceptives on Cervical T-helper 17 Phenotype and Function in Adolescents: Results from a Randomized, Crossover Study Comparing Long-acting Injectable Norethisterone Oenanthate (NET-EN), Combined Oral Contraceptive Pills, and Combined Contraceptive Vaginal Rings Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 71(7): E76-E87
Boehm, H.J.; Boehringer, M.; Bur, D.; Gmuender, H.; Huber, W.; Klaus, W.; Kostrewa, D.; Kuehne, H.; Luebbers, T.; Meunier-Keller, N.; Mueller, F. 2000: Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening Journal of Medicinal Chemistry 43(14): 2664-2674
Garza-Flores, J.; Jimenez-Thomas, S.; Salomón-Andonie, J.; Díaz-Sanchez, V. 1988: Assessment of a new low-dose once-a-month injectable contraceptive Contraception 37(5): 471-481
Taurand, S. 1989: Injectable hormonal progestational contraceptive agents Soins. Gynecologie Obstetrique Puericulture Pediatrie 1989(93): I-Ii
Khan, A.R.; Mosley, W.H.; Jahan, F.A. 1976: Experience with norethisterone enanthate as injectable contraceptive Bangladesh Medical Research Council Bulletin 2(2): 131-138